Microphysiological systems meet hiPSC technology - New tools for disease modeling of liver infections in basic research and drug development

Adv Drug Deliv Rev. 2019 Feb 1:140:51-67. doi: 10.1016/j.addr.2018.06.008. Epub 2018 Jun 15.

Abstract

Complex cell culture models such as microphysiological models (MPS) mimicking human liver functionality in vitro are in the spotlight as alternative to conventional cell culture and animal models. Promising techniques like microfluidic cell culture or micropatterning by 3D bioprinting are gaining increasing importance for the development of MPS to address the needs for more predictivity and cost efficiency. In this context, human induced pluripotent stem cells (hiPSCs) offer new perspectives for the development of advanced liver-on-chip systems by recreating an in vivo like microenvironment that supports the reliable differentiation of hiPSCs to hepatocyte-like cells (HLC). In this review we will summarize current protocols of HLC generation and highlight recently established MPS suitable to resemble physiological hepatocyte function in vitro. In addition, we are discussing potential applications of liver MPS for disease modeling related to systemic or direct liver infections and the use of MPS in testing of new drug candidates.

Keywords: Drug screening; Hepatocyte like cells (HLC); Immune response; Inflammation; Malaria; Stem cells; Viral liver infections; iPSC differentiation.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Drug Development*
  • Humans
  • Induced Pluripotent Stem Cells*
  • Infections*
  • Liver
  • Liver Diseases*
  • Models, Biological